Ryan Langston
Stock Analyst at TD Cowen
(2.17)
# 2,698
Out of 4,681 analysts
12
Total ratings
50%
Success rate
-1.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Buy | $275 → $251 | $201.06 | +24.84% | 3 | Nov 26, 2024 | |
| ELV Elevance Health | Maintains: Buy | $589 → $484 | $410.39 | +17.94% | 2 | Oct 21, 2024 | |
| ASTH Astrana Health | Initiates: Buy | $66 | $44.81 | +47.29% | 1 | Oct 14, 2024 | |
| ADUS Addus HomeCare | Maintains: Buy | $128 → $137 | $123.09 | +11.30% | 4 | Aug 8, 2024 | |
| EHAB Enhabit | Maintains: Market Perform | $12 → $11 | $7.86 | +39.95% | 2 | Mar 11, 2024 |
Universal Health Services
Nov 26, 2024
Maintains: Buy
Price Target: $275 → $251
Current: $201.06
Upside: +24.84%
Elevance Health
Oct 21, 2024
Maintains: Buy
Price Target: $589 → $484
Current: $410.39
Upside: +17.94%
Astrana Health
Oct 14, 2024
Initiates: Buy
Price Target: $66
Current: $44.81
Upside: +47.29%
Addus HomeCare
Aug 8, 2024
Maintains: Buy
Price Target: $128 → $137
Current: $123.09
Upside: +11.30%
Enhabit
Mar 11, 2024
Maintains: Market Perform
Price Target: $12 → $11
Current: $7.86
Upside: +39.95%